|
CA922319A
(en)
|
1964-10-26 |
1973-03-06 |
Pfizer Limited |
Process of preparing 5-nitroimidazole derivatives
|
|
JPS6037735B2
(ja)
|
1978-10-18 |
1985-08-28 |
住友電気工業株式会社 |
人工血管
|
|
IN156886B
(enExample)
|
1981-08-22 |
1985-11-30 |
Council Scient Ind Res |
|
|
NZ210785A
(en)
|
1984-01-13 |
1987-11-27 |
Battelle Development Corp |
Liquid dispersions of layered controlled release dosage forms
|
|
EP0206625B1
(en)
|
1985-06-13 |
1992-09-30 |
Barry James Dr. Marshall |
Compositions for the treatment of gastrointestinal disorders
|
|
US4851521A
(en)
|
1985-07-08 |
1989-07-25 |
Fidia, S.P.A. |
Esters of hyaluronic acid
|
|
GB8607159D0
(en)
|
1986-03-22 |
1986-04-30 |
Smith & Nephew Ass |
Pharmaceutical composition
|
|
JPH01500034A
(ja)
|
1986-04-10 |
1989-01-12 |
ダラテック プロプライエタリー リミテッド |
ワクチンおよび植込剤
|
|
US5140055A
(en)
|
1986-07-01 |
1992-08-18 |
Bridgestone Corporation |
Rubber composition
|
|
US4920141A
(en)
|
1986-10-06 |
1990-04-24 |
Petrolite Corporation |
Synergistic biocides of certain nitroimidazoles and aldehydes
|
|
US5026694A
(en)
|
1987-04-13 |
1991-06-25 |
The British Columbia Cancer Foundation |
Platinum complexes with one radiosensitizing ligand
|
|
US4816339A
(en)
|
1987-04-28 |
1989-03-28 |
Baxter International Inc. |
Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
|
|
FR2625998B1
(fr)
|
1988-01-15 |
1990-06-08 |
Rhone Poulenc Sante |
Procede de preparation d'hydroxyalkyl-1 methyl-2 nitro-5 imidazoles
|
|
FR2625999B1
(fr)
|
1988-01-15 |
1990-06-08 |
Rhone Poulenc Sante |
Procede de preparation d'hydroxyalkyl-1 methyl-2 nitro-5 imidazoles
|
|
FR2625996B1
(fr)
|
1988-01-15 |
1990-06-08 |
Rhone Poulenc Sante |
Procede de preparation d'agents d'hydroxyalkylation, les nouveaux agents ainsi obtenus et leur emploi
|
|
US5614545A
(en)
|
1988-06-09 |
1997-03-25 |
Leonard Bloom |
Topical composition for treatment of blepharitis
|
|
US4957918A
(en)
|
1988-06-09 |
1990-09-18 |
Leonard Bloom |
Topical treatment of blepharitis
|
|
DE3822095A1
(de)
|
1988-06-30 |
1990-01-04 |
Klinge Co Chem Pharm Fab |
Neue arzneimittelformulierung sowie verfahren zu deren herstellung
|
|
DE3900811A1
(de)
|
1989-01-13 |
1990-07-19 |
Kali Chemie Pharma Gmbh |
Neue arzneiform
|
|
IT1230047B
(it)
|
1989-07-04 |
1991-09-27 |
Giovanni Brotzu |
Protesi vascolare contenente nella parete microcapsule inglobanti cellule produttrici di ormoni.
|
|
IE902829A1
(en)
|
1989-08-14 |
1991-02-27 |
Eurand America |
Microencapsulated taste-masked water-insoluble nsaid drug¹materials
|
|
DE3930669A1
(de)
|
1989-09-14 |
1991-03-28 |
Basf Ag |
Verfahren zur herstellung von uretdiongruppen aufweisenden polyisocyanaten
|
|
WO1991017744A1
(en)
|
1990-05-14 |
1991-11-28 |
Jernberg Gary R |
Surgical implant and method incorporating chemotherapeutic agents
|
|
IT1253711B
(it)
|
1991-12-17 |
1995-08-23 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
|
|
IL104093A
(en)
|
1991-12-31 |
1999-06-20 |
Abbott Lab |
Prolamine is expected to mask the taste of drugs given orally
|
|
IT1255895B
(it)
|
1992-10-20 |
1995-11-17 |
Laura Chiodini |
Composizioni farmaceutiche contenenti una calcitonina
|
|
IT1264020B
(it)
*
|
1993-01-28 |
1996-09-09 |
Recordati Chem Pharm |
Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
|
|
ZA9410186B
(en)
|
1994-01-10 |
1995-08-25 |
Santiago Abelardo Bojali Jaber |
Savourless antiamoebic antiprotozoan chemical product and procedure to obtain it
|
|
US5549911A
(en)
|
1994-01-14 |
1996-08-27 |
Laboratoires Des Produits Ethiques Ethypharm |
Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
|
|
ATE187068T1
(de)
*
|
1994-01-14 |
1999-12-15 |
Ethypharm Lab Prod Ethiques |
Mikrogranulate enthaltend 5-nitroimidazolderivate
|
|
US6103262A
(en)
|
1994-01-27 |
2000-08-15 |
G. D. Searle & Company |
Modified-release metronidazole compositions and methods for making and using same
|
|
BR9505962A
(pt)
|
1994-12-21 |
1997-12-23 |
Johnson & Johnson |
Suspensão farmacêutica aquosa e processo para sua preparação
|
|
EP0830135A1
(en)
|
1995-05-09 |
1998-03-25 |
The Procter & Gamble Company |
Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
|
|
US6214386B1
(en)
*
|
1995-11-22 |
2001-04-10 |
Recordati, S.A. |
Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
|
|
FR2759293B1
(fr)
*
|
1997-02-11 |
1999-04-30 |
Ethypharm Lab Prod Ethiques |
Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
|
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
|
US7884090B2
(en)
|
1999-03-17 |
2011-02-08 |
Ernest L. Bonner, Jr. |
Compositions and methods for the treatment of arthritis
|
|
US7691831B2
(en)
|
1999-03-17 |
2010-04-06 |
Ernest L. Bonner, Jr. |
Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
|
|
FR2791888B1
(fr)
|
1999-04-06 |
2004-10-08 |
Ethypharm Lab Prod Ethiques |
Suspension pharmaceutique buvable
|
|
DE60017881T2
(de)
|
1999-04-06 |
2006-04-13 |
Ethypharm |
Trinkbare pharmazeutische suspension von ibuprofen
|
|
KR100671879B1
(ko)
|
1999-07-16 |
2007-01-19 |
가부시키가이샤 쇼에이 |
니트로이미다졸 함유 피부 질환용 외용제
|
|
IT1317735B1
(it)
|
2000-01-26 |
2003-07-15 |
Nicox Sa |
Sali di agenti antimicrobici.
|
|
US6653333B2
(en)
|
2000-01-31 |
2003-11-25 |
Ishihara Sangyo Kaisha, Ltd. |
Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives
|
|
US7234062B2
(en)
|
2000-07-18 |
2007-06-19 |
General Electric Company |
Authentication of remote appliance messages using an embedded cryptographic device
|
|
CA2463624A1
(en)
|
2001-10-15 |
2003-04-24 |
National Research Council Of Canada |
Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
|
|
US20030091540A1
(en)
|
2001-10-16 |
2003-05-15 |
Nawaz Ahmad |
Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
|
|
US20050261298A1
(en)
|
2002-01-18 |
2005-11-24 |
David Solow-Cordero |
Methods of treating conditions associated with an Edg-7 receptor
|
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
|
DE60321400D1
(de)
*
|
2002-05-01 |
2008-07-10 |
Mcneil Ppc Inc |
Erwärmende und nicht irritierende antifungale schmiermittelzubereitung in gelform
|
|
US20040033968A1
(en)
|
2002-08-16 |
2004-02-19 |
Lin Shun Y. |
Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
|
|
US20050186142A1
(en)
|
2002-10-25 |
2005-08-25 |
Foamix Ltd. |
Kit and composition of imidazole with enhanced bioavailability
|
|
JP2006505583A
(ja)
|
2002-10-25 |
2006-02-16 |
フォーミックス エルティーディー． |
化粧剤および医薬用フォーム
|
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US20070292355A1
(en)
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Anti-infection augmentation foamable compositions and kit and uses thereof
|
|
DE10261656A1
(de)
|
2002-12-23 |
2004-07-01 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
US20050026982A1
(en)
|
2003-06-10 |
2005-02-03 |
Soenke Johannsen |
Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient
|
|
JP2007508243A
(ja)
|
2003-08-04 |
2007-04-05 |
フォーミックス エルティーディー． |
両親媒性コポリマーゲル化剤を含む泡坦体
|
|
US20060140990A1
(en)
*
|
2003-09-19 |
2006-06-29 |
Drugtech Corporation |
Composition for topical treatment of mixed vaginal infections
|
|
CN1304002C
(zh)
*
|
2003-12-02 |
2007-03-14 |
浙江巨都集团股份有限公司 |
塞克硝唑阴道泡腾片及其生产方法
|
|
US20050222169A1
(en)
|
2004-01-16 |
2005-10-06 |
Nawaz Ahmad |
Compositions and methods of treating infections
|
|
US8309103B2
(en)
*
|
2004-01-22 |
2012-11-13 |
Alparis, S.A. De C.V. |
Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
|
|
EP1718286A4
(en)
|
2004-01-22 |
2010-03-31 |
Nicox Sa |
NITROSIS AND / OR NITROSYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
|
|
US9016221B2
(en)
|
2004-02-17 |
2015-04-28 |
University Of Florida Research Foundation, Inc. |
Surface topographies for non-toxic bioadhesion control
|
|
US20060024243A1
(en)
|
2004-08-02 |
2006-02-02 |
Agis Industries (1983) Ltd. |
Foamable compositions containing nitro-imidazoles, processes for preparing same and methods of treatment utilizing same
|
|
US7485729B2
(en)
|
2004-08-12 |
2009-02-03 |
King Industries, Inc. |
Organometallic compositions and coating compositions
|
|
WO2006021303A1
(de)
|
2004-08-24 |
2006-03-02 |
Basf Aktiengesellschaft |
Imidazolium-methylsulfite als ausgangsverbindungen zur herstellung ionischer flüssigkeiten
|
|
US20060137684A1
(en)
|
2004-12-01 |
2006-06-29 |
Celeste Evans |
Compositions and methods of treating irritation and kit therefor
|
|
US20060142304A1
(en)
|
2004-12-27 |
2006-06-29 |
Michael Southall |
Method for treating or preventing pruritic and neurogenic skin disorders
|
|
WO2006120495A1
(fr)
|
2005-05-13 |
2006-11-16 |
Advanced Scientific Developements |
Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
|
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
|
CN1789250A
(zh)
|
2005-12-16 |
2006-06-21 |
西安新安医药科技有限公司 |
一组硝基咪唑类衍生物的光学对映体、制备方法及其用途
|
|
US20070154510A1
(en)
|
2005-12-30 |
2007-07-05 |
Wilcher Steve A |
Adsorbent-Containing Hemostatic Devices
|
|
CA2635994A1
(en)
|
2006-01-05 |
2007-07-12 |
Drugtech Corporation |
Drug delivery system for bioadhesion to a vulvovaginal surface
|
|
US20100159035A1
(en)
|
2006-04-04 |
2010-06-24 |
Avner Shemer |
Kit for treating skin infection
|
|
CN1973838A
(zh)
*
|
2006-11-28 |
2007-06-06 |
湖北科益药业股份有限公司 |
塞克硝唑片及其制备方法
|
|
US9398949B2
(en)
|
2007-01-29 |
2016-07-26 |
Emmetropia, Inc. |
Intraocular lens system
|
|
US20110002866A1
(en)
|
2007-10-31 |
2011-01-06 |
Lubit Beverly W |
Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
|
|
US8853247B2
(en)
|
2007-11-02 |
2014-10-07 |
Nektar Therapeutics |
Oligomer-nitroimidazole anti-infective conjugates
|
|
CA2932121A1
(en)
|
2007-11-30 |
2009-06-11 |
Newlink Genetics Corporation |
Ido inhibitors
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US7893097B2
(en)
|
2008-02-02 |
2011-02-22 |
Dow Pharmaceutical Sciences, Inc. |
Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
|
|
SI2247558T2
(sl)
|
2008-02-14 |
2024-10-30 |
Eli Lilly And Company |
Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij
|
|
CN101255175A
(zh)
|
2008-03-28 |
2008-09-03 |
合肥工业大学 |
一种塞克硝唑水溶性盐及其制备方法
|
|
US9493489B2
(en)
|
2008-10-15 |
2016-11-15 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules as anti-protozoal agents
|
|
WO2010141596A2
(en)
|
2009-06-02 |
2010-12-09 |
Marquette University |
Chemical proteomic assay for optimizing drug binding to target proteins
|
|
US8999360B2
(en)
|
2009-10-22 |
2015-04-07 |
Thomas Julius Borody |
Compositions and methods for treating extracellular parasitic infections
|
|
WO2011052522A1
(ja)
|
2009-10-26 |
2011-05-05 |
富士フイルムＲｉファーマ株式会社 |
感染症診断薬
|
|
CA2778181C
(en)
|
2009-10-26 |
2024-05-28 |
Thomas Julius Borody |
Therapy for enteric infections
|
|
WO2012075015A2
(en)
|
2010-11-29 |
2012-06-07 |
Dr. Reddy's Laboratories Ltd. |
Oral metronidazole pharmaceutical compositions
|
|
US9198957B2
(en)
|
2011-01-31 |
2015-12-01 |
The Trustees Of Columbia University In The City Of New York |
Treatment and prevention of bacterial vaginosis and Gardnerella vaginalis infections
|
|
ES2673286T3
(es)
|
2011-02-11 |
2018-06-21 |
Zx Pharma, Llc |
Formulaciones multiparticuladas de L-mentol y métodos relacionados
|
|
WO2012122098A1
(en)
|
2011-03-06 |
2012-09-13 |
King Industries, Inc. |
Compositions of a metal amidine complex and second compound, coating compositions comprising same
|
|
FR2975299B1
(fr)
|
2011-05-16 |
2013-09-27 |
Madeca |
Utilisation du secnidazole dans le traitement des infections dentaires
|
|
CN107669698A
(zh)
|
2011-05-16 |
2018-02-09 |
星法马私人有限公司 |
治疗或预防细菌性阴道病的方法
|
|
CN102266284A
(zh)
|
2011-06-20 |
2011-12-07 |
湖北东信药业有限公司 |
塞克硝唑阴道栓剂及其制备工艺
|
|
WO2013003646A1
(en)
*
|
2011-06-28 |
2013-01-03 |
Medicis Pharmaceutical Corporation |
High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis
|
|
CN102335433B
(zh)
|
2011-10-09 |
2013-01-02 |
广东华南药业集团有限公司 |
用于微丸压片的包衣膜及其制备方法
|
|
US11185562B2
(en)
|
2013-02-04 |
2021-11-30 |
Seres Therapeutics, Inc. |
Compositions and methods for inhibition of pathogenic bacterial growth
|
|
US20140271923A1
(en)
*
|
2013-03-14 |
2014-09-18 |
Christopher Brian Reid |
Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
|
|
AU2015311674B2
(en)
|
2014-09-05 |
2018-03-08 |
Evofem Biosciences, Inc. |
Secnidazole for use in the treatment of bacterial vaginosis
|
|
CN104257626A
(zh)
|
2014-10-14 |
2015-01-07 |
武汉科技大学 |
一种塞克硝唑软胶囊及其制备方法
|
|
CA2988082C
(en)
|
2015-06-01 |
2020-09-29 |
Symbiomix Therapeutics, Llc |
Novel nitroimidazole formulations and uses thereof
|
|
US10596832B2
(en)
|
2018-05-24 |
2020-03-24 |
Xerox Corporation |
Printer and dryer for drying images on coated substrates in aqueous ink printers
|